Skip to main content
. Author manuscript; available in PMC: 2012 Dec 18.
Published in final edited form as: Am J Psychiatry. 2008 Dec 15;166(2):226–233. doi: 10.1176/appi.ajp.2008.07071210

TABLE 2.

Patient Clinical Measures

Variable Men (N=18)
Women (N=12)
Mean SD Mean SD
Age 38.6 10.4 36.0 9.2
Age at onset 20.1 3.8 20.4 8.2
Duration of illness 18.5 9.7 15.6 6.7
Antipsychotic dosage (chlorpromazine equivalents)a 433 319 395 458
Brief Psychiatric Rating Scale score 31.5 11.3 31.0 8.6
Scale for the Assessment of Negative Symptoms
 Total (items 1–22) 33.8 27.8 30.3 17.7
 Affect (items 1–8) 8.6 8.2 5.5 5.6
 Alogia (items 9–13) 3.6 6.0 2.8 2.9
 Avolition (items 14–17) 5.7 5.2 5.3 4.4
 Anhedonia (items 18–22) 8.9 6.7 8.2 6.7
 Attention (items 23–25) 2.6 4.9 2.6 2.8
Scale for the Assessment of Positive Symptoms
 Total (items 1–34) 18.4 21.8 13.1 11.6
 Hallucination items (1–7) 4.4 6.5 7.0 6.8
 Delusion items (8–20) 9.7 11.3 4.2 6.5
 Bizarre behavior items (21–25) 1.4 2.4 0.0 0.0
 Formal thought disorder items (26–34) 2.9 7.4 1.9 4.0
a

Two male patients and two female patients were unmedicated.